483
Michelle Sato, M.D.Michelle Sato, M.D. – FDA 483, Aug 13, 2021
Record Details
An FDA inspection of Michelle Sato, M.D. in Los Angeles, CA, a clinical investigator, revealed significant deficiencies in the conduct of an investigational plan. The firm failed to report all adverse events and lacked adequate oversight of study staff, who made unauthorized changes to study logs and examinations. These findings indicate serious non-compliance with clinical trial regulations.
View Company Profile
ID · 7467947e-d386-4c26-bc5d-ad5b47a5eb9b
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.